Evolve is a clinically designed 5-day calorie restriction protocol delivering approximately 950 kcal per day. The mechanism is real and documented: suppression of mTOR and IGF-1, activation of AMPK, induction of autophagy, and the metabolic shift from glucose to fat oxidation.
The ~950 kcal/day target is not arbitrary. It is the clinically validated boundary between two dangerous zones — and the protocol is calibrated to stay exactly within it across all five days.
Lean muscle catabolism. Electrolyte depletion. Cognitive impairment. Requires continuous medical supervision.
NABL-confirmed daily range across the Evolve protocol. Full metabolic signalling with preserved muscle and cognition.
Insufficient glycogen depletion. mTOR suppression incomplete. The biological switch does not fully engage.
“Below 600 kcal/day without supervision: lean muscle catabolism, electrolyte depletion. Above 1,000 kcal/day: the metabolic signalling that makes restriction therapeutic does not fully activate. The Evolve protocol is engineered to navigate between these two extremes.”
100-person RCT. Three monthly cycles reduced BMI, blood pressure, fasting glucose, IGF-1, and systemic CRP. First large-scale human evidence for 5-day calorie restriction protocols.
Biological age fell by a median of 2.5 years across three cycles. Reduced insulin resistance and hepatic steatosis, independent of overall weight loss.
Primary care study in Type 2 diabetes patients: improved HbA1c and reduced need for diabetes medication at 12 months following the protocol.
3,000 circulating proteins tracked daily across 7-day restriction. Multi-organ adaptations emerge distinctly after Day 3 — establishing the biological necessity of Days 4 and 5.
Direct human evidence of autophagic flux on a 5-day calorie restriction protocol — LC3B-II accumulation and p62 clearance in participants.
The Evolve protocol is grounded in peer-reviewed human trials. These are the primary studies informing the caloric architecture, supplement stack, and timing framework.
A fasting-mimicking diet at reduced but non-starvation caloric levels triggered cellular repair, reduced metabolic risk markers, and improved biological age indicators in human subjects.
View on PubMed ↗Three cycles of a low-calorie, fasting-mimicking protocol significantly reduced markers for diabetes, cardiovascular disease, and aging, including fasting glucose, blood pressure, and IGF-1.
View on PubMed ↗Intermittent caloric restriction produced equivalent or superior improvements in insulin resistance and metabolic markers compared to continuous caloric restriction, with higher compliance rates.
View on PubMed ↗Metabolic switching from glucose to ketone bodies during fasting activates cellular stress-resistance pathways, autophagy, and systemic repair mechanisms that are not triggered by normal feeding.
View on PubMed ↗